Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.

Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Abstract Text:

    jose a karamJose A Karam,shahrokh f shariatShahrokh F Shariat,hong-ying huangHong-Ying Huang,rey-chen pongRey-Chen Pong,raheela ashfaqRaheela Ashfaq,ellen shapiroEllen Shapiro,yair lotanYair Lotan,arthur i sagalowskyArthur I Sagalowsky,xue-ru wuXue-Ru Wu,jer-tsong hsiehJer-Tsong Hsieh,

    PURPOSE: DOC-2/DAB2 (differentially expressed in ovarian carcinoma-2/disabled-2), a potential tumor suppressor gene, is underexpressed in several cancers. Little is known about the expression of this gene in urothelial carcinoma of the bladder (UCB). We profiled DOC-2/DAB2 expression in mouse and human normal and neoplastic urothelia. EXPERIMENTAL DESIGN: Immunohistochemical staining for DOC-2/DAB2 was carried out on tissue specimens from two transgenic mouse models with urothelium-specific molecular alterations and on a tissue microarray containing cores from 9 normal controls, 44 patients who underwent transurethral resection of the bladder tumor (TURBT), 195 patients who underwent radical cystectomy for UCB, and 39 lymph nodes with metastatic UCB. RESULTS: Normal mouse urothelium stained uniformly with DOC-2/DAB2. Weaker staining was observed in low-grade, superficial papillary bladder tumors from transgenic mice harboring constitutively active Ha-Ras, whereas carcinoma in situ-like lesions and high-grade bladder tumors from transgenic mice expressing a SV40 T antigen completely lacked DOC-2/DAB2 expression. In human tissues, DOC-2/DAB2 expression was decreased in 11% of normal bladder specimens, 59% of TURBT specimens, 65% of radical cystectomy specimens, and 77% of the metastatic lymph node specimens. Decreased DOC-2/DAB2 expression was associated with advanced pathologic stage (P = 0.023), lymph node metastases (P = 0.050), and lymphovascular invasion (P < 0.001). In univariable, but not in multivariable analysis, decreased DOC-2/DAB2 was associated with an increased probability of bladder cancer recurrence (log-rank test, P = 0.020) and bladder cancer-specific mortality (log-rank test, P = 0.023). CONCLUSIONS: Decreased DOC-2/DAB2 expression seems to occur early in bladder tumorigenesis and becomes more prominent in advanced stages of UCB.

    Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Publishing Authors By Initials

    ja karamJA Karam,sf shariatSF Shariat,hy huangHY Huang,rc pongRC Pong,r ashfaqR Ashfaq,e shapiroE Shapiro,y lotanY Lotan,ai sagalowskyAI Sagalowsky,xr wuXR Wu,jt hsiehJT Hsieh,

    For similar neoplasms: neoplasms by site: urogenital neoplasms: urologic neoplasms: urinary bladder neoplasms research abstracts see: neoplasms: neoplasms by site: urogenital neoplasms: urologic neoplasms: urinary bladder neoplasms research

    PUBMED ID PMID:

    MEDLINE DATE:

    Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Clinical cancer research : an official journal of

    VOLUME: 13

    Page Numbers: 4400-6

    Journal Abbreviation: Clin. Cancer Res.

    ISSN: 1078-0432

    DAY: 1

    MONTH: Aug

    YEAR: 2007

    Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9502500

    Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Keywords Mesh Terms:

    KEYWORDS: Urinary Bladder Neoplasms

    MESH TERMS: surgery

    Chemical & Substance for Abstract: Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder. Information

    Substance Name: Tumor Markers, Biological

    Registry Number: 0

    Grant and Affiliation Information for Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.

    AFFILIATION: Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCRR

    GRANT: K30-RR022269-08

    ACRONYM: RR

    MEDLINETA: Clin Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News